PATRICE DUQUETTE: Open Payments
NPI 1346339249 · BIRMINGHAM, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 80 payments from 10 companies in 2025. Trend: 2023 $1,257 · 2024 $1,030 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $280 |
| E.R. Squibb & Sons, L.L.C. | 20 | $274 |
| Otsuka America Pharmaceutical, Inc. | 10 | $264 |
| Janssen Pharmaceuticals, Inc | 13 | $208 |
| Alkermes, Inc. | 7 | $153 |
| Indivior Inc. | 6 | $149 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: VRAYLAR, COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, SUBLOCADE, ARISTADA, INGREZZA, ABILIFY MAINTENA.
Industry payments across MI — which companies pay providers there.
